HealthWarehouse.com, Inc (HEWA) Fair Value & Analysis
Healthcare · US · Market cap $8.5M
Fair value as of: Jun 26, 2026
Analysis
HealthWarehouse.com, Inc (HEWA) currently trades at $0.1300, while our model-based Fair Value estimate is $0.1000 — implying the stock looks roughly 23.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
HealthWarehouse.com, Inc. operates an online and mail order pharmacy. It offers pharmacy supplies; diabetic supplies that include test strips, glucose meters, insulin syringes, and pen needles; over-the-counter products, such as products for allergy and sinus, diet and nutrition, digestive health, hair care, pain and fever, and personal care; home medical products; and pet supplies, which include flea and tick products, drugs for pets, and interceptors. The company sells prescription medications and OTC products to individual consumers over the Internet. HealthWarehouse.com, Inc. was founded in 2007 and is headquartered in Florence, Kentucky.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is HealthWarehouse.com, Inc (HEWA) undervalued?
What is the fair value of HEWA?
What is the quality score of HEWA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.